Home/Filings/4/0001127602-24-018717
4//SEC Filing

Belldegrun Arie 4

Accession 0001127602-24-018717

CIK 0001830214other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:26 PM ET

Size

13.3 KB

Accession

0001127602-24-018717

Insider Transaction Report

Form 4
Period: 2024-06-12
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-06-12+105,263194,925 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-12105,2630 total
    Exercise: $0.00Class A Common Stock (105,263 underlying)
  • Award

    Stock Option

    2024-06-13+571,428571,428 total
    Exercise: $0.46Exp: 2034-06-13Class A Common Stock (571,428 underlying)
  • Award

    Restricted Stock Units

    2024-06-13+432,900432,900 total
    Exercise: $0.00Class A Common Stock (432,900 underlying)
Holdings
  • Class A Common Stock

    (indirect: By LLC)
    500,000
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]Bellco Legacy LLC is owned and managed by trusts controlled by the Reporting Person and Rebecka Belldegrun.
  • [F3]In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.
  • [F4]The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date.
  • [F5]In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.

Issuer

Ginkgo Bioworks Holdings, Inc.

CIK 0001830214

Entity typeother

Related Parties

1
  • filerCIK 0001296549

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:26 PM ET
Size
13.3 KB